132 related articles for article (PubMed ID: 6977342)
1. The prognosis of the possible foetal and placental complications during delivery by measuring maternal serum levels of pregnancy-specific beta-1-glycoprotein (SP1).
Karg NJ; Csaba IF; Than GN; Arany AA; Szabó DG
Arch Gynecol; 1981; 231(1):69-73. PubMed ID: 6977342
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunoassay of SP1 (pregnancy-specific beta1-glycoprotein) in maternal blood and in amniotic fluid normal and pathologic pregnancies.
Würz H; Geiger W; Künzig HJ; Jabs-Lehmann A; Bohn H; Lüben G
J Perinat Med; 1981; 9(2):67-78. PubMed ID: 6787188
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy-specific beta 1-glycoprotein (SP1) in serum from women with pregnancies complicated by intrauterine growth retardation.
Tamsen L; Johansson SG; Axelsson O
J Perinat Med; 1983; 11(1):19-25. PubMed ID: 6601703
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of three biochemical fetoplacental tests: serum human placental lactogen, pregnancy-specific beta 1-glycoprotein, and urinary estrogens, and their relationship to placental insufficiency.
MacDonald DJ; Scott JM; Gemmell RS; Mack DS
Am J Obstet Gynecol; 1983 Oct; 147(4):430-6. PubMed ID: 6605089
[TBL] [Abstract][Full Text] [Related]
5. [Detection of pregnancy-specific beta 1-glycoproteins (SP1) and pregnancy-associated plasma protein A (PAPP-A) in maternal serum. Diagnostic significance in intrauterine fetal retardation].
Briese V; Straube W
Zentralbl Gynakol; 1984; 106(8):517-23. PubMed ID: 6203263
[TBL] [Abstract][Full Text] [Related]
6. An endocrine model for the diagnosis of intrauterine growth retardation as demonstrated by the determination of total estrogen and pregnandiol 24-hour urinary excretion in 222 at risk pregnancies.
Wolfrum R; Bordasch C; Holweg J
J Perinat Med; 1975; 3(4):248-59. PubMed ID: 1225959
[TBL] [Abstract][Full Text] [Related]
7. Abnormally elevated pregnancy specific beta 1 glycoprotein (SP1 beta) with very low placental lactogen (hPL) concentrations in a pregnancy with satisfactory outcome.
Pledger DR; McEwan HP
Acta Obstet Gynecol Scand; 1984; 63(7):663-5. PubMed ID: 6393689
[TBL] [Abstract][Full Text] [Related]
8. [Plasma levels of HCS and beta SP1 in normal and pathological pregnancies].
Merger C; Guinot N; Blanc B; Ruf H
J Gynecol Obstet Biol Reprod (Paris); 1982; 11(5):573-82. PubMed ID: 6757310
[TBL] [Abstract][Full Text] [Related]
9. [Value of the rapid microimmunochemical test for trophoblastic globulin for predicting fetal viability].
Zaitseva IV; Shmakov GS; Terent'eva TA; Vasileĭskiĭ SS
Akush Ginekol (Mosk); 1986 Jun; (6):19-21. PubMed ID: 2944407
[No Abstract] [Full Text] [Related]
10. Circulating levels of pregnancy specific beta 1-glycoprotein (SP1) in normal pregnancy and in intrauterine growth retardation.
Lee JN; Huang SC; Ouyang PC; Wei PY; Al-Ani AT; Chard T
Taiwan Yi Xue Hui Za Zhi; 1980 Nov; 79(11):986-9. PubMed ID: 6973005
[No Abstract] [Full Text] [Related]
11. Concentrations of placental proteins (HPL and SP1) in maternal serum throughout normal pregnancy.
Baur MP; Bellmann O; Tebbe J; Lang N
Arch Gynecol; 1982; 231(2):153-8. PubMed ID: 6803682
[TBL] [Abstract][Full Text] [Related]
12. Effect of smoking on maternal blood SP1 levels in late pregnancy.
Lee JN; Grudzinskas JG; Chard T
Obstet Gynecol; 1981 Feb; 57(2):220-3. PubMed ID: 6970355
[TBL] [Abstract][Full Text] [Related]
13. [Study of serum SP1 levels in early normal and abnormal pregnancies].
Zhang WY
Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):95-7, 124-5. PubMed ID: 2364798
[TBL] [Abstract][Full Text] [Related]
14. [Placental tissue concentration of pregnancy-associated proteins in early and term pregnancies].
Ito M; Imaizumi H; Hayakawa S; Katou K; Nishiyama Y; Sugiyama Y; Nose Y
Nihon Naibunpi Gakkai Zasshi; 1983 Jul; 59(7):993-1003. PubMed ID: 6195024
[TBL] [Abstract][Full Text] [Related]
15. Human placental lactogen and pregnancy-specific beta 1-glycoprotein in pregnant diabetic women.
Pledger DR; Lunan CB; Belfield A
Br J Obstet Gynaecol; 1982 Oct; 89(10):827-30. PubMed ID: 6751380
[TBL] [Abstract][Full Text] [Related]
16. Further evidence for syncytiotrophoblastic localization of beta 1-SP1-glycoprotein.
Guaschino S; Bagliani F; Pesando P; Bolis PF; Gaeta E
Basic Appl Histochem; 1980; 24(3):209-12. PubMed ID: 7004434
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pregnancy-specific beta 1-glycoprotein (SP1) and ultrasound in predicting the date of delivery.
Naiem A; Bersinger NA; Keller PJ; Schneider H
Br J Obstet Gynaecol; 1988 Feb; 95(2):116-9. PubMed ID: 3280007
[TBL] [Abstract][Full Text] [Related]
18. Concentration of placental protein 10 (PP10) in maternal serum and amniotic fluid throughout normal gestation and in pregnancy complicated by fetal growth retardation.
Würz H; Lüben G; Bohn H; Künzig HJ; Geiger W
Arch Gynecol; 1983; 233(3):165-74. PubMed ID: 6605116
[TBL] [Abstract][Full Text] [Related]
19. Identification of high-risk pregnancy by the routine measurement of pregnancy-specific beta 1-glycoprotein.
Grudzinskas JG; Gordon YB; Menabawey M; Lee JN; Wadsworth J; Chard T
Am J Obstet Gynecol; 1983 Sep; 147(1):10-2. PubMed ID: 6604456
[TBL] [Abstract][Full Text] [Related]
20. The concentrations of SP1 beta and SP1 alpha in retroplacental and peripheral blood at term.
Ahmed AG; Klopper A
Eur J Obstet Gynecol Reprod Biol; 1983 Oct; 16(2):77-81. PubMed ID: 6196240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
